中基長壽科學(00767.HK)終止合資協議及解散合資公司
格隆匯7月2日丨中基長壽科學(00767.HK)公告,於2024年2月26日,公司全資附屬公司深圳市中基健康科學有限公司("中基健康")與成都冠德堂生物科技集團有限公司("冠德堂")訂立合資協議,以在中國成立一間合資公司。
有見市場及經濟環境不斷轉變,公司與上述對手方已達成協議及友好解決,自願終止合資協議及解散合資公司。任何一方均無權就解散向另一方索償任何損失、損害或開支。解散上述合資公司須待取得中國有關政府部門的批準後,方告完成及生效。因此,集團不會因解散上述合資公司而產生任何現金收益或錄得任何重大現金流出。
董事會認爲,解散合資公司不會對集團的財務表現及營運造成重大不利影響。儘管解散合資公司,但長遠而言,集團對未來業務前景仍感樂觀,並將繼續審慎推行營商計劃,冀望在業界回暖時更好地把握商機。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.